DermaSensor device study for suspicious skin spots
Part of Cancer, Skin clinical trials.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have a skin spot that your doctor thinks might be melanoma.
- The spot can be reached by a small handheld scanner (not inside ears, under nails, or on the soles of your feet).
- The spot is not on or near scars, cuts, or areas that have been biopsied before.
- The spot is 2.5mm to 15mm across (about the size of a pencil eraser).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device (Dermalyser) that estimates how thick a suspected melanoma is by analyzing a dermoscopy image. It may help doctors plan surgery without needing extra procedures.
This study uses a device called LumAssure to scan skin conditions. It is testing whether the device can help doctors assess skin spots or growths without needing a biopsy.
This study tests a device that uses a special light to image skin lesions after applying an FDA-approved cream. It aims to see if the device can help doctors see benign skin growths more clearly before they are removed.
This trial studies a way to help trained clinicians evaluate skin spots (melanocytic lesions) using dermoscopy and augmented histology. It may help improve how consistently lesions are assessed, based on using an online digital tool.
This study compares two systems that take pictures of your whole skin to find melanoma early. You might qualify if you have a higher risk for melanoma, such as having had melanoma before, many moles, or a strong family history.
This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.
Hear when a new Melanoma (Skin) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.